Michele Bortolini
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 10%
Papers in
- Surgery 4
- Lipoproteins and Cardiovascular Health 3
-
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Alberto Corsini (3 shared papers)Matthew B. Wright (2 shared papers)Martin Bopst (2 shared papers)Moh Tadayyon (1 shared paper)F Fiaccadori (1 shared paper)C. Di Padova (1 shared paper)C. Surrenti (1 shared paper)M Frezza (1 shared paper)
- Journals
- Drug Safety (2 papers)The American Journal of Cardiology (2 papers)Pharmacoepidemiology and Drug Safety (1 paper)Expert Opinion on Drug Safety (1 paper)Molecular Endocrinology (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Michele Bortolini
10 papers receiving 630 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 171
- Hepatology 77
- Biochemistry 31
- Endocrinology, Diabetes and Metabolism 64
- Clinical Biochemistry 27
Countries citing papers authored by Michele Bortolini
This map shows the geographic impact of Michele Bortolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bortolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bortolini more than expected).
Fields of papers citing papers by Michele Bortolini
This network shows the impact of papers produced by Michele Bortolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bortolini. The network helps show where Michele Bortolini may publish in the future.
Co-authors
The 25 scholars most cited alongside Michele Bortolini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 133 | |
| 2 | 2014 | 131 | |
| 3 | 1990 | 122 | |
| 4 | 2001 | 65 | |
| 5 | 2012 | 62 | |
| 6 | 2012 | 36 | |
| 7 | 2012 | 36 | |
| 8 | 2002 | 29 | |
| 9 | 2003 | 17 | |
| 10 | 2015 | 14 |
About Michele Bortolini
Michele Bortolini is a scholar working on Surgery, Pharmacology, Molecular Biology, Oncology and Epidemiology, having authored 10 papers that have together received 645 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Pharmacology (171 citations), Hepatology (77 citations), Biochemistry (31 citations), Endocrinology, Diabetes and Metabolism (64 citations) and Clinical Biochemistry (27 citations). Michele Bortolini has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Alberto Corsini, Matthew B. Wright, Martin Bopst, Moh Tadayyon, F Fiaccadori, C. Di Padova, C. Surrenti, M Frezza, G Manzillo and Bogdana Balas. Their work appears in journals such as Drug Safety, The American Journal of Cardiology, Pharmacoepidemiology and Drug Safety, Expert Opinion on Drug Safety and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.